These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 29926994
21. Immunomodulatory effect of long-term oclacitinib maleate therapy in dogs with atopic dermatitis. De Caro Martins G, da Costa-Val AP, Coura FM, Diamantino GML, Nogueira MM, de Oliveira Melo-Junior OA, Giunchetti RC, da Silveira-Lemos D, Melo MM. Vet Dermatol; 2022 Apr; 33(2):142-e40. PubMed ID: 34747068 [Abstract] [Full Text] [Related]
22. Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL-31-induced pruritus. Fleck T, Norris L, King V, Lesman S, Gonzales AJ. J Vet Pharmacol Ther; 2022 Jul; 45(4):380-384. PubMed ID: 35586953 [Abstract] [Full Text] [Related]
23. Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis. Visser M, Walsh K, King V, Sture G, Caneva L. BMC Vet Res; 2022 Mar 17; 18(1):103. PubMed ID: 35300697 [Abstract] [Full Text] [Related]
25. A randomised, double-blinded trial to assess the effect of oclacitinib and prednisolone on intradermal allergen and prick tests in dogs with atopic dermatitis. Baretta LT, do Espírito Santo Cunha V, Figueiredo CD, Gerardi DG. Vet Dermatol; 2024 Feb 17; 35(1):71-80. PubMed ID: 37770410 [Abstract] [Full Text] [Related]
26. The influence of treatment with lokivetmab on transepidermal water loss (TEWL) in dogs with spontaneously occurring atopic dermatitis. Szczepanik M, Wilkołek P, Gołyński M, Sitkowski W, Taszkun I, Toczek W. Vet Dermatol; 2019 Aug 17; 30(4):330-e93. PubMed ID: 31090122 [Abstract] [Full Text] [Related]
27. Prolonged twice-daily administration of oclacitinib for the control of canine atopic dermatitis: a retrospective study of 53 client-owned atopic dogs. Denti D, Caldin M, Ventura L, De Lucia M. Vet Dermatol; 2022 Apr 17; 33(2):149-e42. PubMed ID: 35014745 [Abstract] [Full Text] [Related]
32. Stratum corneum removal facilitates experimental sensitization to mite allergens in atopic dogs. Olivry T, Wofford J, Paps JS, Dunston SM. Vet Dermatol; 2011 Apr 17; 22(2):188-96. PubMed ID: 21143539 [Abstract] [Full Text] [Related]
33. Rapid response of hyperkeratotic erythema multiforme to oclacitinib in two dogs. High EJ, Linder KE, Mamo LB, Levy BJ, Herrmann I, Bizikova P. Vet Dermatol; 2020 Aug 17; 31(4):330-e86. PubMed ID: 32307815 [Abstract] [Full Text] [Related]
35. Studies on the role of routes of allergen exposure in high IgE-producing beagle dogs sensitized to house dust mites. Marsella R, Nicklin C, Lopez J. Vet Dermatol; 2006 Oct 17; 17(5):306-12. PubMed ID: 16961815 [Abstract] [Full Text] [Related]
39. Proof of concept of the preventive efficacy of high-dose recombinant mono-allergen immunotherapy in atopic dogs sensitized to the Dermatophagoides farinae allergen Der f 2. Olivry T, Paps JS, Dunston SM. Vet Dermatol; 2017 Apr 17; 28(2):183-e40. PubMed ID: 28261915 [Abstract] [Full Text] [Related]
40. Sensitization to peanut, egg or pets is associated with skin barrier dysfunction in children with atopic dermatitis. Sherenian MG, Kothari A, Biagini JM, Kroner JW, Baatyrbek Kyzy A, Johannson E, Atluri G, He H, Martin LJ, Khurana Hershey GK. Clin Exp Allergy; 2021 May 17; 51(5):666-673. PubMed ID: 33721370 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]